Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
233 Needham St. Suite 300
Newton, MA 02464Phone+1 617-293-7738
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1979 - 1982
Boston University Medical CenterInternship, Internal Medicine, 1976 - 1977
Penn MedicinePost-Doctoral Fellowship, 1976 - 1977
Perelman School of Medicine at the University of PennsylvaniaClass of 1976
Certifications & Licensure
MA State Medical License 1982 - 2025
WI State Medical License 2014 - 2021- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Cytopathology
Awards, Honors, & Recognition
- Diamond Award Harvard Pilgrim Healthcare, 1995
- Peer Recognition Award Harvard Pilgrim HealthCare, 1993
Publications & Presentations
PubMed
- 121 citationsThe stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia.David A. Ahlquist, William R. Taylor, Douglas W. Mahoney, Hongzhi Zou, Michael J. Domanico
Clinical Gastroenterology and Hepatology. 2012-03-01 - 103 citationsClinical performance of an automated stool DNA assay for detection of colorectal neoplasia.Graham P. Lidgard, Michael J. Domanico, Janelle J. Bruinsma, James Light, Zubin D. Gagrat
Clinical Gastroenterology and Hepatology. 2013-10-01 - 52 citationsMultitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening PopulationLinda J.W. Bosch, Veerle Melotte, Sandra Mongera, Kathleen L.J. Daenen, Veerle M.H. Coupé
The American Journal of Gastroenterology. 2019-12-01
Journal Articles
- Multitarget Stool DNA Testing for Colorectal-Cancer Screening,Imperiale TF, Ransohoff, Itzkowitz DF, Levin TR, Lavin P Lidgard GP, Ahlquist DA, Berger BM, N Engl J Med, 4/3/2014
Press Mentions
Naveris to Showcase Advances in Precision Surveillance for HPV-Associated Oropharyngeal Cancer Using the NavDx® Test at the 2024 ASTRO Annual MeetingSeptember 28th, 2024- Naveris Collaborators Present Award-Winning Abstract at ASTRO 2022 on Potential of NavDx to Inform Treatment Strategies in HPV-Driven CancersOctober 24th, 2022
- Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-Driven Head and Neck Cancer with NavDx in DART 2.0 Clinical TrialApril 13th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
